The US economy continues to recover, even though the GDP growth fell short of expectations in the second quarter, mainly because labor and product shortages across various sectors offset the rapid surge in service activity. Still, much of the service sector, which dominates the US economy, had reopened for business between April and June thanks to the vaccination program.
In the second quarter, the GDP rose at an annualized rate of just 6.5%, well below the 8.5% rate expected by analysts, and showing a small acceleration from the 6.4% recorded in Q1. This is still preliminary data, and the figures might be revised upwards.
The important thing is that the economy has recovered to pre-pandemic levels. The Federal Reserve is generally satisfied with the recovery, thinking about reducing the bond-buying program, though it failed to set a timeline during its latest meeting ended Thursday.
Scott Hoyt, a senior economist at Moody’s (NYSE:MCO) Analytics, told Reuters:
“The US economy is off and running. Real GDP has fully recovered what it lost in the downturn. The economy is well ahead of much of the rest of the world, save China and some parts of southeast Asia, in its recovery from the pandemic recession.”
Stock indexes, including OTCQX Composite, continue to fluctuate near their all-time highs, as the Fed hasn’t slowed its quantitative easing. Now is a great time to invest in OTC penny stocks.
OTC MARKETS THE PLACE TO BE
There are many good OTC penny stocks that can boost your portfolio’s value in the long term. For investors, we preach the key to trading hot OTC stocks is finding momentum BEFORE it happens and then be patient.
We always alert our subscribers first before we publish for our regular readers. This is the value of having a subscription to Insider Financial, which you can sign up for here. We alert our subscribers with our best ideas before our regular readers.
If you watch the Insider Financial YouTube channel, you can get a sense of the ideal time to book profits. We warned our subscribers not to get greedy or get caught up in the diamond hands/paper hands BS.
We also recommend you own a portfolio of OTC stocks. For some, that can be as many as 10 to 20 or more OTC stocks. This provides diversification and allows one to manage the market’s moods much easier. It also helps to own shares in the following 4 trending OTC stocks gaining momentum.
Today, we’ll look at 4 trending OTC penny stocks that will greatly reward patient investors. They are Halberd Corp (OTCPK: HALB), Peak Fintech Group (OTCQX: PKKFF), Cybernetic Technologies Ltd (OTCPK: HPIL), and MC Endeavors, Inc (OTCPK: MSMY).
OTC Penny Stocks to Watch #1 HALB
Halberd Corp has been correcting on Thursday, but it still has gained over 27% over the last five days. On Wednesday, the share price hovered above $0.05 for a while, hitting the highest level since the beginning of April. In mid-March, the OTC stock reached its year-to-date high at $0.081.
HALB is a pharmaceutical company that develops and explores unique treatments against several diseases, including Alzheimer’s, Cancer, Fibromyalgia, and Multiple Sclerosis, among others. Interestingly, the company has a treatment for COVID-19, which it is currently trialing and seeking to get approval. Specifically, HALB researches and develops antibodies and devices for the prevention, detection, and treatment of several diseases through laboratory, hospital, and clinical trials.
We were surprised to see that a $20 million company has really big goals. HALB is not only researching and exploring treatments. It has two patents issued before 2010 – ‘Sequential Extracorporeal Treatment of Bodily Fluids’ and ‘Utilization of Stents for the Treatment of Blood Borne Carcinomas’ – and at least four provisional patents, all of which relate to COVID-19. They are:
- Method for Treating and Curing Covid-19 Infection;
- Method for Treating Covid-19 Inflammatory Cytokine Storm for the Reduction of Morbidity and Mortality in Covid-19 Patients;
- Method for Treating and Curing Covid-19 Infection by Utilizing a Laser to Eradicate the Virus;
- Nasal Spray To Prevent The Transmission Of Covid-19 Between Humans
HALB is really centered on COVID. It has been dormant since at least 2014, and became Pink Current again in 2020, as the company came to life specifically to create COVID treatments. William A. Hartman was appointed as the new CEO.
In fact, HALB proposes several methods to treat COVID. One of them is applicable to any disease and entails the extracorporeal treatment of a patient’s blood or cerebrospinal fluid (CSF) consisting of a three-step process:
- Removal of the bodily fluid from the patient;
- Introduction of one or more antibody-antigen complexing agents to bind with the target disease antigen(s) (i.e., coronavirus associated antigen(s)) and removal of the antibody-antigen complex by any number of available methods (mechanical, chemical, or molecular filtering; dialysis; molecular adsorbent recirculating system (MARS); plasmapheresis, etc.) alone, or in combination;
- Return of the cleansed bodily fluid to the patient.
This process is meant to be conducted as a continuous flow process, similar to dialysis. In another treatment method that uses similar steps, HALB uses laser technology to eradicate the coronavirus from the fluid.
Last year, HALB was quite active, securing $2 million for its COVID trials and establishing a subsidiary in the UK.
At the end of 2020, it announced its proprietary, highly potent, neutralizing antibody against SARS-CoV-2. In April of this year, the company said that its two patent-pending monoclonal antibodies had demonstrated a strong affinity and neutralizing capabilities against three of the identified SARS-CoV-2 mutations. Last month, HALB announced two new neutralizing antibodies against the Spike Protein of SARS-CoV-2, both with a stronger binding affinity than the two monoclonal antibodies.
Meanwhile, HALB started to focus on eradicating Alzheimer’s, which has become a problem for over 10% of people aged 65 and older in Western countries, including the US. In June, Halberd started experimentations to eradicate three of the principal components of Alzheimer’s disease through its patented extracorporeal treatment process that can slow or stop the progress of the disease.
$HALB dropped a stellar PR last week with regards to advancing their patent-pending Alzheimer’s treatment. Huge addressable market with Alzheimer’s.
Fantastic share structure.
Get these 2’s while ya can!
— Net Prophet (@HighFloor84) July 26, 2021
Dr. Mitchell S. Felder, Halberd Corporation’s CTO and the inventor of Halberd’s technology, explained:
“We believe the most efficient methodology to eliminate the building blocks of neurofibrillary tangles is to physically remove them from cerebral spinal fluid (CSF). Because of the blood-brain barrier, we believe effective treatment cannot be delivered through ingested or injected medications. Throughout history, this fact has been an impenetrable obstacle to combating Alzheimer’s disease – until now. Halberd’s approach, by contrast to all prior attempts, operates directly at the source — on cerebral spinal fluid. We believe that our approach is the only possible way to overcome the blood-brain barrier issue.”
On Wednesday, HALB was bullish as it established a ‘proof of concept’ taking a major step towards the elimination of multiple infectious diseases, such as malaria, tuberculosis, sepsis, meningitis, and pandemics, among others, by successfully eliminating E. Coli bacteria through the use of its patent-pending laser emissive energy exposure technique.
There is so much to say about HALB that we really don’t understand why it’s so undervalued. We think this might be an explosive OTC stock if it succeeds with its trials and commercializes its unique technology.
— Canadian Jennifer 🇨🇦 (@cdntradegrljenn) July 22, 2021
OTC Penny Stocks to Watch #2 PKKFF
Canada-based Peak Fintech Group Inc is a bigger company compared to most businesses we cover, but it can grow even bigger. In fact, PKKFF is currently preparing to reach on NASDAQ, and this is a big event for investors.
The share price has been quite volatile during the last few days. In mid-July, the price started to surge from about $3 to over $4.50, but it then collapsed to $2 on July 27, as the company implemented its 2:1 share consolidation scheme. The price then quickly came back above $4 the very next day, currently trading at $4.18.
Peak Fintech is the parent company of a group of innovative fintech subsidiaries operating in China’s commercial lending industry. Peak provides a bridge for North American investors to participate in the continued digitization of China’s financial services industry and its rapidly expanding Fintech sector. Through its subsidiaries, Peak uses technology, analytics, and artificial intelligence (AI) to create an ecosystem of lenders, borrowers, and other participants in China’s commercial lending space, where lending operations are conducted rapidly, safely, efficiently, and with the utmost transparency.
Peak’s main subsidiary operates a lending platform in China that matches lending institutions and borrowers and charges a fee of between 1% and 4% of the value of those loans. It targets primarily small and micro-businesses. The business operating in China has expanded to a $65 million revenue run rate, and Peak expects it to reach $90 million in annual revenues in 2021. Despite the pandemic, Peak reported revenue growth of 265% in 2020, while its losses to common shareholders increased to $1.9 million from losses of $1.3 million on a non-GAAP basis. It reached and surpassed its target of $40 million in revenues but fell short of its original $4 million EBITDA target.
Last week, the company released its revenue guidance for the coming years, which grabbed investors’ attention immediately.
With over $600 million in revenue and over $100 million in net profit, PKKFF is expected to become huge.
“Revenue growth is expected to be mostly organic with just a handful of strategic acquisitions mixed in to complement our existing technology and bring more value to our clients,” the company said.
Speaking about acquisitions, last Monday, PKKFF announced that it made an important step towards acquiring Zhongke Software Intelligence Ltd – a banking AI software provider. Peak transferred Zhongke’s IP to one of its subsidiaries.
On July 29, Peak said it had acquired a minority stake in China UnionPay subsidiary Rongbang Technology Ltd.
All in all, we’re quite impressed with Peak’s fast-growing business and are bullish on it. PKKFF is targeting China’s underserved and credit-strapped SMEs with financial resources to manage and grow their businesses – a huge market that is measured in the hundreds of billions of dollars.
Just finished powerful zoom with CEO Joseph Johnson that investors will not want to miss!
* $105 MILLION Revenue Projected This Year
* $305M 2022
* $625M 2023
* NASDAQ within 3 weeks
* M&A + ⏫ $$ Revisions August
OUT TOMORROW! pic.twitter.com/HTKHfQMhQW
— AGORACOM – George (@AGORACOM) July 28, 2021
Also, the company is going to Nasdaq, which will allow institutions to jump on board the PKKFF train.
OTC Penny Stocks to Watch #3 HPIL
Cybernetic Technologies Ltd has been bullish during the last few days, currently trying to break above a strong resistance near $0.007. The share price has gained over 40% during the last five days. Since the beginning of the year, HPIL has surged about 3,300%, and it still has room for growth as the company is working to become Pink Current. As you may know, these are the types of plays we love here at Insider Financial. Some of our biggest runners have been OTC stocks getting current.
HPIL is currently trading at $0.0068. We first reported on HPIL for our subscribers at the beginning of June when it was trading at just $.002 a share.
As we see it, HPIL is undervalued with such an ambitious CEO and big goals. HPIL CEO Stephen Brown is developing a fast-growing business through multiple partnerships and acquisitions. The company rebranded from HPIL Holding to Cybernetic Technologies only recently.
Earlier this year, HPIL has acquired 100% of NFT Procurement Ltd, which has already partnered with Origin Protocol, a well-known blockchain project focused on non-fungible tokens (NFTs) and decentralized finance (DeFi) – two of the fastest-growing trends within the cryptocurrency space. The collaboration enables NFT Procurement to issue NFTs and offer them for sale to third parties on a website created by Origin and displaying its IP on a dot-com subdomain owned by HPIL. Last week, NFT Procurement said that it was launching its first NFT auction on August 10. The first three auctions are nftjanisjoplin.com, nftspicegirls.com, and nftmarilynmonroe.com.
In May, HPIL announced that it had entered into a Letter of Intent to acquire 100% of Crank Virtual, a division of Crank Media Inc.
Last month, Cybernetic Technologies said that it had acquired World Gaming Group Inc, which had been working on blockchain projects and had developed “GAMEZCASH” and “TUNEZCASH” – two tokens to be used as a new form of currency in the esports/gaming world and the online music industry. Earlier in July, World Gaming Group announced that it had finished building ZIPPA – a unique multi-gaming global platform for gamers that is set to launch on September 1. The platform is about to compete with the likes of ‘TWITCH’,’TIKTOK’ and ‘TRILLER’.
CEO Stephen Brown said:
“This platform is so unique where all gamers can join on many different levels and will be able to earn the token called GAMEZCASH and use it to purchase many items supported by the associate vendors on Zippa. This has been under development and now almost ready to launch.”
Two weeks ago, HPIL launched a new subsidiary called Medusa Intel Technology Ltd, which aims to tap into the world of Artificial Intelligence (AI) along with select partners the company has been working with for the past few months. Two days later, Medusa said that it would launch META DATA ANALYTICS, which is a tracking program that will use algorithms along with its own program to be used in the entertainment industry first and to then potentially expand to other areas.
Cybernetic Technologies announces it has signed an NDA with ANSYS https://www.ansys.com/ to enter into discussions about how the two will work together on the companies Apogee D7 and its Power Train Management System, currently in development.
Besides operating in the blockchain, AI, and NFT space, which are the hottest technologies with tremendous potential, HPIL is also working on its own electric vehicle – can you imagine it? Last month, it partnered with a group led by L. Ferrox Tutinean to launch Apogee Dynamics Ltd – a company that Cybernetic Technologies is a majority owner of. HPIL said it was developing its own electric vehicle called APOGEE D7, using the powertrain developed by Tutinean and Apogee Dynamics Ltd. In mid-July, HPIL signed an NDA with ANSYS (https://www.ansys.com/) to enter into discussions about how the two will work together on Apogee D7 and its Power Train Management System, currently in development.
All in all, HPIL is growing rapidly and it has enormous potential. Think about it – the company operates in blockchain, AI, and electric vehicles. There aren’t many OTC companies manufacturing their own electric automobile if any. HPIL is poised to continue climbing.
OTC Penny Stocks to Watch #4 MSMY
MC Endeavors, Inc has been moving inside a horizontal channel during the last few days, but it keeps trading near the year-to-date high at $0.0299.
The Pink Current company, which is doing business as Eclipse Liquids LLC, is the parent of CBD Liquid Labs. MSMY provides clients with turnkey CBD product production services including research and development, component sourcing, custom formulation, brand and labels design, label printing, contract and wholesale, custom private label manufacturing, and lab-certified third-party testing to ensure a full service, one-stop-shop experience.
Eclipse Liquids brings CBD product manufacturing solutions to a breadth of markets, including consumer health and wellness, personal care and cosmetics, pharmaceuticals and nutraceuticals, pets, sports, lifestyle fitness, and e-liquid tobacco; helping customers introduce innovative products, reduce their time to market, and enhance the overall competitiveness of their CBD product line.
What we like about MSMY is that it provides a wide range of CBD products and is still exploring ways to expand.
The company’s CEO, Steven Mazurek, has been appointed about two years ago and has managed to transform the business, which got the Pink Current status only a few months ago. He is now working to increase production capacity and scale operations, which will be reflected in the revenue and profit figures. The company is cash sufficient to operate and it has not diluted shares since the new CEO came in. He revealed that the company has several plans for expansion within the next few months.
He confirmed that there was no plan for a reverse split in the future.
We think that MSMY is moving in the right direction and has great potential to hit the $1 mark sooner than later.
THE FINAL NOTE
Today is a great opportunity to benefit from the stock market’s bullishness and invest in OTC stocks with great potential during a reviving economy. Our job is to identify the best OTC stock alerts with strong fundamentals and let our subscribers pick the ones they like to build a well-diversified portfolio oriented at penny stocks.
All of the 4 OTC stocks discussed today are on the rise and are good stocks to hold. Nevertheless, our best advice is to be patient and enter the market during corrections. Buying dips and selling rips as swing trades remains the best strategy in the penny stock market. Still, whenever an OTC stock is in the middle of a bull run, we recommend our subscribers to book profits.
It’s very important to eye OTC stocks that have room for growth and have yet to make their explosive move. There are plenty of opportunities, and we take our time to monitor hundreds of penny stocks to buy each week, trying to find the best alerts for our subscribers.
Remember, all you need is one or two OTC stocks to succeed in order to crush the market averages.
As always, good luck to all (except the shorts)!
WHEN INSIDER FINANCIAL HAS A STOCK ALERT, IT CAN PAY TO LISTEN. AFTER ALL, OUR FREE NEWSLETTER HAS FOUND MANY TRIPLE-DIGIT WINNERS FOR OUR SUBSCRIBERS. WE SPECIALIZE IN FINDING MOMENTUM BEFORE IT HAPPENS!
Disclosure: We have no position in any of the securities mentioned. We wrote this article ourselves and it expresses our own opinions. We are not receiving compensation for it. We have no business relationship with any company whose stock is mentioned in this article. Insider Financial is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. This article is not a solicitation or recommendation to buy, sell, or hold securities. This article is meant for informational and educational purposes only and does not provide investment advice.